News Releases
 Print Email

Syngenta Biotechnology, Inc. Completes First Phase of Long-term Expansion Plan

6/8/2010

  • Syngenta Biotechnology, Inc. completes move into 100,000 square foot Keystone facility
  • Move allows renovation and expansion in its main RTP biotechnology center
  • Next phase includes demolition at a newly acquired 50-acre site 
  • Syngenta has occupied facilities in the Triangle for more than 25 years
RESEARCH TRIANGLE PARK, N.C., USA — Syngenta Biotechnology, Inc., (SBI) today announced it has completed moving into its newly leased, 100,000 square foot facility at Keystone Office Park. Moving into this new space concluded the first phase of a longer-term growth plan that will supplement the existing Cornwallis Drive facility, which celebrated its 25th anniversary last December.
 
SBI serves as the key North American location for plant gene technology research for Syngenta and employs over 400. The additional office building was leased in response to strong growth at the facility, with 60 percent of current employees hired in the past five years. SBI will occupy both locations until the current expansion plan is completed.
 
“As the biotechnology industry continues to grow, SBI is staying on top of the curve by expanding to meet customer and company needs,” said Bill Hlavac, head of site operations for SBI. “This new space allows us to continue our day-to-day activities comfortably while providing the flexibility to renovate lab and other facilities at the Cornwallis location as needed.”
 
The Keystone facility features a more open work environment with a variety of meeting areas designed to foster collaboration and teamwork. SBI will make the commute seamless with regular shuttles between the two sites during the workday.
 
The overall vision of the SBI expansion is to create an integrated campus for plant biotechnology research that supports the company’s goal of helping to feed the growing world population. The company purchased 50 acres on Davis Drive, adjacent to its current site, in late 2009 to help facilitate the vision of a united campus by creating expansion options. The Keystone site will serve as an interim solution until the campus is fully developed. 
 
“Our expansion plan remains flexible, but with Keystone and Davis Drive we have a number of options available to us,” said Hlavac. “We can now focus on how to best meet our customers’ needs here in the Triangle, where we will continue to be a part of the community for a long time to come.”
 
Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
 
 
###
 
Media contacts:
Paul Minehart
Syngenta Corporation 
paul.minehart@syngenta.com
 
Casey Novak
Gibbs & Soell, Inc. Public Relations
cnovak@gibbs-soell.com, 919-870-5718
 
Related Links:
The Syngenta logo is a registered trademark of a Syngenta Group Company.
 
Cautionary Statement Regarding Forward-Looking Statements
 
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.